cabergoline has been researched along with Subarachnoid Hemorrhage in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gemmete, JJ; Hollon, TC; Khalsa, SS; Pandey, AS; Shastri, R; Trobe, JD | 2 |
De Tommasi, A; De Tommasi, C; Guastamacchia, E; Losa, M; Luzzi, S; Resta, F; SabbĂ , C; Tafaro, E; Terreni, MR; Triggiani, V | 1 |
3 other study(ies) available for cabergoline and Subarachnoid Hemorrhage
Article | Year |
---|---|
Spontaneous subarachnoid hemorrhage due to ruptured cavernous internal carotid artery aneurysm after medical prolactinoma treatment.
Topics: Aneurysm, Ruptured; Antineoplastic Agents; Cabergoline; Carotid Artery, Internal; Cavernous Sinus; Cerebral Angiography; Ergolines; Humans; Male; Middle Aged; Prolactinoma; Rupture, Spontaneous; Skull Base; Subarachnoid Hemorrhage | 2016 |
Spontaneous subarachnoid hemorrhage due to ruptured cavernous internal carotid artery aneurysm after medical prolactinoma treatment.
Topics: Aneurysm, Ruptured; Cabergoline; Carotid Artery Diseases; Carotid Artery, Internal; Cavernous Sinus; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Skull Base; Subarachnoid Hemorrhage; Treatment Outcome | 2017 |
Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
Topics: Adult; Cabergoline; Carcinoma; Combined Modality Therapy; Disease Progression; Dopamine Agonists; Drug Resistance; Ergolines; Fatal Outcome; Female; Humans; Octreotide; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Subarachnoid Hemorrhage | 2007 |